Atenção!


O atendimento às questões referentes ao Repositório Institucional será interrompido entre os dias 20 de dezembro de 2024 a 5 de janeiro de 2025.

Pedimos a sua compreensão e aproveitamos para desejar boas festas!

 

Neurocysticercosis: The enigmatic disease

dc.contributor.authorAgapejev, Svetlana [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:26:15Z
dc.date.available2014-05-27T11:26:15Z
dc.date.issued2011-12-01
dc.description.abstractNeurocysticercosis (NCC) is an infection of the central nervous system (CNS) caused by the metacestode larval form of the parasite Taenia sp. Many factors can contribute to the endemic nature of cysticercosis. The inflammatory process that occurs in the tissue surrounding the parasite and/or distal from it can result from several associated mechanisms and may be disproportionate with the number of cysts. This discrepancy may lead to difficulty with the proper diagnosis in people from low endemic regions or regions that lack laboratory resources. In the CNS, the cysticerci have two basic forms, isolated cysts (Cysticercus cellulosae = CC) and racemose cysts (Cysticercus racemosus = CR), and may be meningeal, parenchymal, or ventricular or have a mixed location. The clinical manifestations are based on two fundamental syndromes that may occur in isolation or be associated: epilepsy and intracranial hypertension. They may be asymptomatic, symptomatic or fatal; have an acute, sub-acute or chronic picture; or may be in remission or exacerbated. The cerebrospinal fluid (CSF) may be normal, even in patients with viable cysticerci, until the patients begin to exhibit the classical syndrome of NCC in the CSF, or show changes in one or more routine analysed parameters. Computed tomography (CT) and magnetic resonance imaging (MRI) have allowed non-invasive diagnoses, but can lead to false negatives. Treatment is a highly controversial issue and is characterised by individualised therapy sessions. Two drugs are commonly used, praziquantel (PZQ) and albendazole (ABZ). The choice of anti-inflammatory drugs includes steroids and dextrochlorpheniramine (DCP). Hydrocephalus is a common secondary effect of NCC. Surgical cases of hydrocephalus must be submitted to ventricle-peritoneal shunt (VPS) immediately before cysticidal treatment, and surgical extirpation of the cyst may lead to an absence of the surrounding inflammatory process. The progression of NCC may be simple or complicated, have remission with or without treatment and may exhibit symptoms that can disappear for long periods of time or persist until death. Unknown, neglected and controversial aspects of NCC, such as the impaired fourth ventricle syndrome, the presence of chronic brain oedema and psychic complaints, in addition to the lack of detectable glucose in the CSF and re-infection are discussed. © 2011 Bentham Science Publishers.en
dc.description.affiliationBotucatu Medical School São Paulo State University (UNESP), 18618-970, Botucatu, São Paulo
dc.description.affiliationUnespBotucatu Medical School São Paulo State University (UNESP), 18618-970, Botucatu, São Paulo
dc.format.extent261-284
dc.identifierhttp://dx.doi.org/10.2174/1871524911106040261
dc.identifier.citationCentral Nervous System Agents in Medicinal Chemistry, v. 11, n. 4, p. 261-284, 2011.
dc.identifier.doi10.2174/1871524911106040261
dc.identifier.issn1871-5249
dc.identifier.issn1875-6166
dc.identifier.scopus2-s2.0-84855787355
dc.identifier.urihttp://hdl.handle.net/11449/72894
dc.language.isoeng
dc.relation.ispartofCentral Nervous System Agents in Medicinal Chemistry
dc.relation.ispartofsjr0,423
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectClinical manifestations
dc.subjectDiagnosis
dc.subjectEpidemiology
dc.subjectIncidence
dc.subjectNeurocysticercosis
dc.subjectProphylaxis
dc.subjectReferences
dc.subjectTreatment
dc.subjectalbendazole
dc.subjectantiinflammatory agent
dc.subjectdexchlorpheniramine
dc.subjectpraziquantel
dc.subjectsteroid
dc.subjectacute disease
dc.subjectbrain ventricle peritoneum shunt
dc.subjectchronic disease
dc.subjectcomputer assisted tomography
dc.subjectCysticercus
dc.subjectCysticercus cellulosae
dc.subjectcysticercus racemosus
dc.subjectdisease course
dc.subjectdisease exacerbation
dc.subjectepilepsy
dc.subjectfatality
dc.subjecthuman
dc.subjecthydrocephalus
dc.subjectintracranial hypertension
dc.subjectneurocysticercosis
dc.subjectnuclear magnetic resonance imaging
dc.subjectreinfection
dc.subjectremission
dc.subjectTaenia
dc.subjectAnimals
dc.subjectHost-Parasite Interactions
dc.subjectHumans
dc.subjectSteroids
dc.subjectTaenia solium
dc.subjectWorld Health
dc.titleNeurocysticercosis: The enigmatic diseaseen
dc.typeArtigo
dcterms.licensehttp://eurekaselect.com/209
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentNeurologia, Psicologia e Psiquiatria - FMBpt

Arquivos